SS Innovations International, Inc. (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were used in successful telesurgeries at two international medical conferences in October 2026. The demonstrations underscore the company's progress in enabling remote robotic surgery, a development that could significantly alter how specialized surgical care is delivered, particularly to underserved regions.
At the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting in Barcelona, Spain, Chairman and CEO Dr. Sudhir Srivastava performed a robotic-assisted cardiac procedure remotely on a patient located approximately 7,500 miles away in Bengaluru, India. This feat highlights the SSi MantrAsana console's ability to facilitate real-time surgery across vast distances through ultra-low latency connectivity, high-definition visualization, and precise instrument control. The implications are profound: such technology could allow expert surgeons to operate on patients in remote or underserved areas without the need for travel, potentially reducing disparities in access to specialized care.
Separately, at the Society of Robotic Surgery India (SRS India) Conference in New Delhi, four surgeons completed four distinct robotic-assisted telesurgeries, covering kidney, colorectal, pediatric urological, and gynecological procedures. These diverse cases demonstrate the versatility of the SSi Mantra system across multiple surgical specialties, suggesting broader applicability beyond cardiac surgery. As of October 23, 2026, a total of 205 telesurgeries, including complex cardiac procedures, had been performed using the SSi Mantra system, according to the company.
The SSi Mantra system is a modular, multi-arm robotic platform featuring 3 to 5 robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, and a touch panel monitor for patient information. It supports over 40 different types of robotic endo-surgical instruments, including 5mm instruments for pediatric and ENT surgeries. The optional SSi MantrAsana tele-surgeon console is a portable, compact alternative to the standard command center, designed to provide equivalent control functionality while enabling enhanced portability and telesurgery capability. The system has been clinically validated in India for more than 190 different types of surgical procedures.
Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. The company's vision is to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. For more information, visit ssinnovations.com or the company's LinkedIn page. The full press release is available at https://ibn.fm/Ujtlm, and the latest news and updates relating to SSII can be found in the company's newsroom at https://ibn.fm/SSII.
This announcement matters because it signals a step forward in the commercialization of telesurgery, a field with the potential to reshape healthcare delivery by enabling remote operations. If validated at scale, such technology could help address surgeon shortages and improve access to specialized procedures in rural and underserved areas worldwide. For investors, the successful demonstrations may bolster confidence in SS Innovations' ability to compete in the growing surgical robotics market. The news was distributed by TechMediaWire, a communications platform focused on technology companies, which is part of the Dynamic Brand Portfolio at IBN. TechMediaWire provides access to wire solutions via InvestorWire and other corporate communications solutions. Full terms of use and disclaimers are available on the TechMediaWire website.
